226950 — OliX Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Market Cap
KR₩934bn
Enterprise Value
KR₩962bn
Revenue
KR₩6bn

Annual balance sheet for OliX Pharmaceuticals, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	68,111	49,757	61,872	25,925	12,414
Net Total Accounts Receivable
Net Total Receivables	518	552	1,147	5,283	1,082
Total Inventory
Prepaid Expenses
Total Current Assets	69,047	52,240	65,046	32,142	15,534
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,180	31,525	37,232	43,910	51,385
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	78,577	86,672	132,651	102,825	71,249
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,488	40,365	39,543	6,563	30,060
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	33,292	68,151	66,744	52,971	53,400
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	45,286	18,521	65,907	49,855	17,849
Total Liabilities & Shareholders' Equity	78,577	86,672	132,651	102,825	71,249
Total Common Shares Outstanding
Total Preferred Shares Outstanding